COMPLEX THERAPY OF ORAL CANDIDIASIS AMONG PATIENTS WITH IMMUNODEFICIENCY DESEASES
Keywords:
oral candidiasis, probiotics, antifungal drugs, thrush, Candida albicans.Abstract
Oral candidiasis, commonly referred to as “thrush,” involves infections of the tongue and other areas of the oral mucosa and is characterized by fungal overgrowth and invasion of superficial tissues. Oral candidiasis is a common fungal infection that affects the oral mucosa and is mainly caused by Candida albicans. Depending on the state of the host’s defense system and the state of the oral microflora, Candida can transform from a harmless commensal into a pathogenic organism that causes oral infection of the mucous membranes. Antifungal drugs are the mainstay of treatment for oral candidiasis in adults. These medications are designed to kill or inhibit the growth of Candida fungus. Probiotics have the potential to modulate the oral immune response to candidiasis. Their ability to enhance local immunity, reduce inflammation and regulate the immune response makes them a promising tool for both the treatment and prevention of oral candidiasis.
References
1. Khalilova U. A., Tumarenko A. V., Skvortsov V. V. Oral candidiasis and its local therapy //Medical nurse. – 2019. – T. 21. – No. 7. – pp. 16-21.
2. Khasanova, L., Yunuskhodzhaeva, M., Rustamova, M. Combination therapy for candidiasis of the oral mucosa. //Journal of Dentistry and Craniofacial Research, 2022.- 2(2), 22–24.
3. Yunuskhodzhaeva M., Rustamova M. Improving the principles of treatment of patients with fungal and bacterial-fungal stomatitis under the basis of a removable laminar denture with complete absence of teeth // Journal of Dentistry and Craniofacial Research. – 2021. – T. 2. – No. 2. – pp. 62-64.
4. Fakhim H, Vaezi A, Javidnia J, Nasri E, Mahdi D, Diba K, Badali H. Candida africana vulvovaginitis: Prevalence and geographical distribution. //J Mycol Med. 2020 Sep;30(3):100966.
5. Garcia-Cuesta C, Sarrion-Perez MG, Bagan JV. Current treatment of oral candidiasis: A literature review. J Clin Exp Dent.2014; 6(5):e576-82
6. Lewis MAO, Williams DW. Diagnosis and management of oral candidosis. //Br Dent J. 2017 Nov 10;223(9):675-681.
7. Manik A, Bahl R. A review on oral candidal infection. J Adv Med Dent Sci Res. 2017;5(3):54-57
8. Parslow BY, Thornton CR. Continuing Shifts in Epidemiology and Antifungal Susceptibility Highlight the Need for Improved Disease Management of Invasive Candidiasis. //Microorganisms. 2022 Jun 13;10(6):1208.
9. Patel M. Oral Cavity and Candida albicans: Colonization to the Development of Infection. //Pathogens. 2022 Mar 10;11(3):335.
10. Patel PN, Sah P, Chandrashekar C, Vidyasagar S, Venkata Rao J, Tiwari M, Radhakrishnan R. Oral candidal speciation, virulence and antifungal susceptibility in type 2 diabetes mellitus. Diabetes Res Clin Pract. 2017 Mar;125:10-19.
11. Patil A, Susmitha HR, Basappa S. Drug-induced Oral Candidiasis: A Case Report. IJSS Case Reports & Reviews 2016;2(12):1-4
12. Peixoto LR, Rosalen PL, Ferreira GLS, et al. Antifungal activity, mode of action and anti-biofilm effects of Laurus nobilis Linnaeus essential oil against Candida spp. //Arch Oral Biol. 2017;73:179–185.
13. Peng DS, Lo CH, Tseng YL, Kuo SL, Chiang CP, Chiang ML. Efficacy of oral nystatin treatment for patients with oral mucosal dysesthesia but without objective oral mucosal manifestations and necessity of Candida culture test before oral nystatin treatment. //J Dent Sci. 2022 Oct;17(4):1802-1813.
14. Rautemaa R, Ramage G. Oral candidosis—clinical challenges of a biofilm disease. Crit Rev Microbiol. 2011 Nov;37(4):328-36.
15. Richardson R, Antilla VJ. Suun hiivainfektioiden diagnostiikka ja hoitoperiaatteet [Diagnosis and treatment of oral candidosis].// Duodecim. 2010;126(2):174-80.
16. Rodero CF, Fioramonti Calixto GM, Cristina Dos Santos K, et al. Curcumin-loaded liquid crystalline systems for controlled drug release and improved treatment of vulvovaginal candidiasis. Mol Pharm. 2018;15(10):4491–4504.
17. Romo JA, Pierce CG, Chaturvedi AK, Lazzell AL, McHardy SF, Saville SP, Lopez-Ribot JL. Development of Anti-Virulence Approaches for Candidiasis via a Novel Series of Small-Molecule Inhibitors of Candida albicans Filamentation. mBio. 2017 Dec 5;8(6):e01991-17.
18. Sankari SL, Gayathri K, Balachander N, et al. Candida in potentially malignant oral disorders. J Pharm Bioall Sci. 2015;7:S 162- 4.
19. Singh A, Verma R, Murari A, et al. Oral candidiasis: An overview. J Oral Maxillofac Pathol.2014;18:81-5.
20. Williams D, Lewis M. Pathogenesis and treatment of oral candidiasis. J Oral Microbiol. 2011;3:1-11.
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
